RxDoctor Payments Data

Kenneth Cohen

Medical Oncology · Chicago, ILNPI 1881787067

Payments from drug & device makers

What this record shows

That places this record below the midpoint for medical oncology clinicians in IL, where the typical reported total is $1,059.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$171,184in research payments, 2019–2025

Across 9 payments — averaging $19,020 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$162K
  • Jazz Pharmaceuticals Inc.$9K

How this compares

$0 in reported general payments places this provider in the 5th percentile of 144 medical oncology providers in Illinois.

See all medical oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$34,533
Medicare patients
233
Services billed
308

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImbruvicaIbrutinib28$548,738
CalquenceAcalabrutinib Maleate13$149,584
EliquisApixaban108$140,878
XareltoRivaroxaban68$95,063
Enoxaparin Sodium25$6,568
Tranexamic Acid17$2,121
Acyclovir15$371
Warfarin Sodium33$270

Paid to pharmacies, not to this prescriber.

Other medical oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →